Table 1.
Demographic and clinical characteristics of participants who likely have chronic pain and those who likely do not have chronic pain
| Participant characteristics | Chronic pain (n = 14) N (%) |
No chronic pain (n = 19) N (%) |
P value |
|---|---|---|---|
| Age (median, IQR) | 36 (23-36) | 29 (30.5-44) | .042∗ |
| Sex, female | 7 (50.0) | 8 (42.1) | .65† |
| Genotype | |||
| HbSS | 7 (50.0) | 14 (73.6) | .364† |
| HbSC | 6 (42.9) | 4 (21.1) | |
| HbSβ+ | 1 (7.1) | 1 (5.3) | |
| Hydroxyurea use | 9 (64.3) | 17 (89.4) | .106† |
| Taking at least 1 type of opioid | 12 (85.7) | 13 (68.4) | .416† |
| Taking acetaminophen, ibuprofen, or naproxen | 7 (50.0) | 14 (73.7) | .459† |
| Treated for pain in the hospital or clinic in the past 3 months | 11 (78.6) | 7 (36.8) | .017† |
| Pain frequency in a typical month | |||
| No pain at all | 0 | 3 (15.8) | N/A |
| 1-2 times a month | 0 | 9 (47.4) | |
| 1-2 times a week | 0 | 5 (26.3) | |
| More than 10 times a month | 2 (14.3) | 1 (5.3) | |
| 3-4 times a week | 4 (28.6) | 0 | |
| 5-6 times a week | 0 | 1 (5.3) | |
| Everyday | 8 (57.1) | 0 | |
Significant P values are shown in bold.
∗
Mann-Whitney U test.
†
χ2 test or Fisher exact test.